ArticleCureus2025
Bandage Contact Lens-Assisted Plaque Brachytherapy for Anterior Segment Tumors: A Novel Technique to Prevent Corneal Complications.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Anterior segment tumors pose challenges in treatment due to their location and potential for globe loss. Plaque brachytherapy allows globe salvage, but placing plaques over the cornea and limbus may lead to epithelial defects and ulcers. We report a novel technique using a bandage contact lens as a buffer between the plaque and cornea in a 48-year-old woman with iridociliary melanoma. The lens thickness (0.07 mm) was included in radiation dose planning. The patient had no corneal complications and showed tumor regression at seven months. Two additional patients treated similarly showed stable tumors and no adverse effects at six months. This method may offer a safer alternative to amniotic membrane grafts for anterior segment brachytherapy, reducing corneal toxicity without compromising tumor control.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.